InvestorsHub Logo
Followers 30
Posts 2777
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Thursday, 10/22/2020 2:09:34 PM

Thursday, October 22, 2020 2:09:34 PM

Post# of 40
The company and TScan Therapeutics have entered into a research collaboration and license agreement to explore development of TCR-T cell therapies for the treatment of COVID-19.

The allo T-cell platform will be used in combination with TScan's immunodominant epitopes and TCR sequences for the development and commercialisation of TCR-T cell therapies.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PSTX News